drugset / Trial / NCT00794456

Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety

NCT00794456 ↗

Phase 3 Completed 150 enrolled Marjan Industria e Comercio ltda
RandomizedParallel-groupDouble-blindTreatment

Summary

Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L. on mild and moderate anxiety. The treatment period will last 6 weeks and be followed by a post treatment visit. Hamilton anxiety scale will be used to assess anxiety.

Timeline

Start
2009-09
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Crataegus Oxyacantha L Traditional medicine (herbal / TCM) — Oral
Subject Passiflora incarnata L Traditional medicine (herbal / TCM) — Oral
Subject Salix alba L Unknown — Oral
Comparator Valeriana Unknown 50 mg Oral

Indications